<i>In silico and in vivo</i> toxicity assessment of cysteamine-modified nanoparticles: implications for pharmacotherapy application
This investigation presents the <i>in vivo</i> safety analysis and pharmacological potential of cysteamine-modified silver nanoparticles (CYST-AgNPs), suggesting enhanced therapeutic activity.
Authors
- Babatunde Alabi (ORCID: https://orcid.org/0000-0002-0198-3331)
- O.A. Adesanya
- Fisayo Nathaniel Ogunleye
- Benneth Ben‐Azu (ORCID: https://orcid.org/0000-0003-3569-3575)
- Sodiq Kolawole Lawal (ORCID: https://orcid.org/0000-0002-8598-4058)
- Samuel Oluwaseun Olojede (ORCID: https://orcid.org/0000-0002-1000-7412)
- A.O. Suleiman
- Diana Odey Ochuole
Institutions
- University of Botswana (BW)
- Delta State University (NG)
- University of Victoria (CA)
- Osun State University (NG)
- Kampala International University in Tanzania (TZ)
- University of Pretoria (ZA)
- Delta State University (US)
- Walter Sisulu University (ZA)
Publication Details
- Journal
- Toxicology Mechanisms and Methods
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1080/15376516.2025.2538128
- Primary Topic
- Biomedical Research and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00